Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Functional respiratory imaging: heterogeneity of acute exacerbations of COPD.

van Geffen WH, Hajian B, Vos W, De Backer J, Cahn A, Usmani OS, Van Holsbeke C, Pistolesi M, Kerstjens HA, De Backer W.

Int J Chron Obstruct Pulmon Dis. 2018 May 30;13:1783-1792. doi: 10.2147/COPD.S152463. eCollection 2018.

2.

Evaluation of a Trial Period With a Sleep Position Trainer in Patients With Positional Sleep Apnea.

Beyers J, Dieltjens M, Kastoer C, Opdebeeck L, Boudewyns AN, De Volder I, Van Gastel A, Verbraecken JA, De Backer WA, Braem MJ, Van de Heyning PH, Vanderveken OM.

J Clin Sleep Med. 2018 Apr 15;14(4):575-583. doi: 10.5664/jcsm.7048.

PMID:
29609712
3.

The Role of Functional Respiratory Imaging in Treatment Selection of Children With Obstructive Sleep Apnea and Down Syndrome.

Slaats MALJ, Loterman D, van Holsbeke C, Vos W, Van Hoorenbeeck K, de Backer J, de Backer W, Wojciechowski M, Boudewyns A, Verhulst S.

J Clin Sleep Med. 2018 Apr 15;14(4):651-659. doi: 10.5664/jcsm.7064.

PMID:
29609707
4.

Changes in ventilation-perfusion during and after an COPD exacerbation: an assessment using fluid dynamic modeling.

Hajian B, De Backer J, Vos W, van Geffen WH, De Winter P, Usmani O, Cahn T, Kerstjens HA, Pistolesi M, De Backer W.

Int J Chron Obstruct Pulmon Dis. 2018 Mar 6;13:833-842. doi: 10.2147/COPD.S153295. eCollection 2018.

5.

Clinical Predictors of Residual Sleep Apnea after Weight Loss Therapy in Obese Adolescents.

Van Eyck A, De Guchtenaere A, Van Gaal L, De Backer W, Verhulst SL, Van Hoorenbeeck K.

J Pediatr. 2018 May;196:189-193.e1. doi: 10.1016/j.jpeds.2017.12.056. Epub 2018 Mar 1.

PMID:
29502877
6.

Machine Learning Algorithms Utilizing Quantitative CT Features May Predict Eventual Onset of Bronchiolitis Obliterans Syndrome After Lung Transplantation.

Barbosa EJM Jr, Lanclus M, Vos W, Van Holsbeke C, De Backer W, De Backer J, Lee J.

Acad Radiol. 2018 Sep;25(9):1201-1212. doi: 10.1016/j.acra.2018.01.013. Epub 2018 Feb 19.

PMID:
29472146
7.

Development of a Clinical Pathway and Technical Aspects of Upper Airway Stimulation Therapy for Obstructive Sleep Apnea.

Vanderveken OM, Beyers J, Op de Beeck S, Dieltjens M, Willemen M, Verbraecken JA, De Backer WA, Van de Heyning PH.

Front Neurosci. 2017 Sep 21;11:523. doi: 10.3389/fnins.2017.00523. eCollection 2017. Review.

8.

The role of ethnicity in the upper airway in a Belgian paediatric population with obstructive sleep apnoea.

Slaats M, Vos W, Van Holsbeke C, De Backer J, Loterman D, De Backer W, Boudewyns A, Verhulst S.

Eur Respir J. 2017 Oct 5;50(4). pii: 1701278. doi: 10.1183/13993003.01278-2017. Print 2017 Oct. No abstract available.

PMID:
28982766
9.

Pathophysiological mechanism of long-term noninvasive ventilation in stable hypercapnic patients with COPD using functional respiratory imaging.

Hajian B, De Backer J, Sneyers C, Ferreira F, Barboza KC, Leemans G, Vos W, De Backer W.

Int J Chron Obstruct Pulmon Dis. 2017 Jul 28;12:2197-2205. doi: 10.2147/COPD.S136412. eCollection 2017.

10.

Predicting the effect of treatment in paediatric OSA by clinical examination and functional respiratory imaging.

Slaats M, Vos W, Van Holsbeke C, De Backer J, Loterman D, De Backer W, Boudewyns A, Verhulst S.

Pediatr Pulmonol. 2017 Jun;52(6):799-805. doi: 10.1002/ppul.23684. Epub 2017 Mar 7.

PMID:
28267299
11.

Sleep-disordered breathing, systemic adipokine secretion, and metabolic dysregulation in overweight and obese children and adolescents.

Van Eyck A, Van Hoorenbeeck K, De Winter BY, Van Gaal L, De Backer W, Verhulst SL.

Sleep Med. 2017 Feb;30:52-56. doi: 10.1016/j.sleep.2015.11.014. Epub 2015 Dec 8.

PMID:
28215263
12.

Sleep disordered breathing and autonomic function in overweight and obese children and adolescents.

Van Eyck A, Van Hoorenbeeck K, De Winter BY, Van Gaal L, De Backer W, Verhulst SL.

ERJ Open Res. 2016 Dec 12;2(4). pii: 00038-2016. doi: 10.1183/23120541.00038-2016. eCollection 2016 Oct.

13.

Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep.

Randerath W, Verbraecken J, Andreas S, Arzt M, Bloch KE, Brack T, Buyse B, De Backer W, Eckert DJ, Grote L, Hagmeyer L, Hedner J, Jennum P, La Rovere MT, Miltz C, McNicholas WT, Montserrat J, Naughton M, Pepin JL, Pevernagie D, Sanner B, Testelmans D, Tonia T, Vrijsen B, Wijkstra P, Levy P.

Eur Respir J. 2017 Jan 18;49(1). pii: 1600959. doi: 10.1183/13993003.00959-2016. Print 2017 Jan.

14.

Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension.

Hajian B, De Backer J, Vos W, Van Holsbeke C, Ferreira F, Quinn DA, Hufkens A, Claes R, De Backer W.

Int J Chron Obstruct Pulmon Dis. 2016 Jul 5;11:1533-41. doi: 10.2147/COPD.S106480. eCollection 2016.

15.

Efficacy of inhaled medications in asthma and COPD related to disease severity.

Hajian B, De Backer J, Vos W, Aerts J, Cluckers J, De Backer W.

Expert Opin Drug Deliv. 2016 Dec;13(12):1719-1727. Epub 2016 Jun 30. Review.

PMID:
27292454
16.

Assessment of lung deposition and analysis of the effect of fluticasone/salmeterol hydrofluoroalkane (HFA) pressurized metered dose inhaler (pMDI) in stable persistent asthma patients using functional respiratory imaging.

De Backer J, Van Holsbeke C, Vos W, Vinchurkar S, Dorinsky P, Rebello J, Mangale M, Hajian B, De Backer W.

Expert Rev Respir Med. 2016 Aug;10(8):927-33. doi: 10.1080/17476348.2016.1192464. Epub 2016 Jun 1.

PMID:
27227384
17.

Erratum to: Pneumococcal lower respiratory tract infections in adults: an observational case-control study in primary care in Belgium.

Flamaing J, De Backer W, Van Laethem Y, Heijmans S, Mignon A.

BMC Fam Pract. 2016 Mar 2;17:25. doi: 10.1186/s12875-016-0420-4. No abstract available.

18.

Functional respiratory imaging to assess the interaction between systemic roflumilast and inhaled ICS/LABA/LAMA.

Vos W, Hajian B, De Backer J, Van Holsbeke C, Vinchurkar S, Claes R, Hufkens A, Parizel PM, Bedert L, De Backer W.

Int J Chron Obstruct Pulmon Dis. 2016 Feb 4;11:263-71. doi: 10.2147/COPD.S93830. eCollection 2016.

19.

Functional respiratory imaging (FRI) for optimizing therapy development and patient care.

Hajian B, De Backer J, Vos W, Van Holsbeke C, Clukers J, De Backer W.

Expert Rev Respir Med. 2016 Feb;10(2):193-206. doi: 10.1586/17476348.2016.1136216.

PMID:
26731531
20.

The role of nocturnal pulse oximetry in the screening for obstructive sleep apnea in obese children and adolescents.

Van Eyck A, Lambrechts C, Vanheeswijck L, Van Hoorenbeeck K, Haentjens D, Boudewyns A, De Winter BY, Van Gaal L, De Backer W, Verhulst SL.

Sleep Med. 2015 Nov;16(11):1409-1412. doi: 10.1016/j.sleep.2015.07.023. Epub 2015 Aug 18.

PMID:
26498244
21.

An Administrator's Perspective on the Organization of Physical Activity for Older Adults in Long-Term Care Facilities.

Baert V, Gorus E, Calleeuw K, De Backer W, Bautmans I.

J Am Med Dir Assoc. 2016 Jan;17(1):75-84. doi: 10.1016/j.jamda.2015.08.011. Epub 2015 Oct 1.

PMID:
26432625
22.

Determinants of Objective Compliance During Oral Appliance Therapy in Patients With Sleep-Disordered Breathing: A Prospective Clinical Trial.

Dieltjens M, Verbruggen AE, Braem MJ, Wouters K, Verbraecken JA, De Backer WA, Hamans E, Van de Heyning PH, Vanderveken OM.

JAMA Otolaryngol Head Neck Surg. 2015 Oct;141(10):894-900.

PMID:
26402736
23.

Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.

Prime D, de Backer W, Hamilton M, Cahn A, Preece A, Kelleher D, Baines A, Moore A, Brealey N, Moynihan J.

J Aerosol Med Pulm Drug Deliv. 2015 Dec;28(6):486-97. doi: 10.1089/jamp.2015.1224. Epub 2015 Sep 15.

24.

Introducing a core curriculum for respiratory sleep practitioners.

Mitchell S, Simonds A, Andreas S, Bonsignore MR, Cooper B, Donic V, McNicholas WT, Morrell M, Palange P, Prest G, Riha R, Trang H, Randerath W, van der Grinten C, Verbraecken J, de Backer W.

Breathe (Sheff). 2015 Mar;11(1):50-6. doi: 10.1183/20734735.020414. Review.

25.

Pneumococcal lower respiratory tract infections in adults: an observational case-control study in primary care in Belgium.

Flamaing J, De Backer W, Van Laethem Y, Heijmans S, Mignon A.

BMC Fam Pract. 2015 May 27;16:66. doi: 10.1186/s12875-015-0282-1. Erratum in: BMC Fam Pract. 2016;17:25.

26.

Estimation of post-operative forced expiratory volume by functional respiratory imaging.

Janssens A, Vos W, Van Holsbeke C, Van Schil P, Oostveen E, De Backer J, Carp L, Snoeckx A, De Backer W, van Meerbeeck JP.

Eur Respir J. 2015 Feb;45(2):544-6. doi: 10.1183/09031936.00168314. Epub 2014 Dec 23. No abstract available.

27.

Upper airway imaging in pediatric obstructive sleep apnea syndrome.

Slaats MA, Van Hoorenbeeck K, Van Eyck A, Vos WG, De Backer JW, Boudewyns A, De Backer W, Verhulst SL.

Sleep Med Rev. 2015 Jun;21:59-71. doi: 10.1016/j.smrv.2014.08.001. Epub 2014 Aug 21. Review.

PMID:
25438733
28.

A promising concept of combination therapy for positional obstructive sleep apnea.

Dieltjens M, Vroegop AV, Verbruggen AE, Wouters K, Willemen M, De Backer WA, Verbraecken JA, Van de Heyning PH, Braem MJ, de Vries N, Vanderveken OM.

Sleep Breath. 2015 May;19(2):637-44. doi: 10.1007/s11325-014-1068-8. Epub 2014 Oct 22.

29.

Epidemiology and outcome of invasive pneumococcal disease among adults in Belgium, 2009-2011.

Verhaegen J, Flamaing J, De Backer W, Delaere B, Van Herck K, Surmont F, Van Laethem Y, Van Damme P, Peetermans W.

Euro Surveill. 2014 Aug 7;19(31):14-22.

30.

The effects of extrafine beclometasone/formoterol (BDP/F) on lung function, dyspnea, hyperinflation, and airway geometry in COPD patients: novel insight using functional respiratory imaging.

De Backer J, Vos W, Vinchurkar S, Van Holsbeke C, Poli G, Claes R, Salgado R, De Backer W.

J Aerosol Med Pulm Drug Deliv. 2015 Apr;28(2):88-99. doi: 10.1089/jamp.2013.1064. Epub 2014 Jul 8.

PMID:
25004168
31.

Sleep-disordered breathing and pulmonary function in obese children and adolescents.

Van Eyck A, Van Hoorenbeeck K, De Winter BY, Van Gaal L, De Backer W, Verhulst SL.

Sleep Med. 2014 Aug;15(8):929-33. doi: 10.1016/j.sleep.2014.03.024. Epub 2014 May 20.

PMID:
24985758
32.

Determinants of baseline lung function and bronchodilator response in 4-year-old children.

Dom S, Weyler JJ, Droste JH, Hagendorens MM, Dierckx E, Bridts CH, De Backer W, Oostveen E.

Eur Respir J. 2014 Aug;44(2):371-81. doi: 10.1183/09031936.00100813. Epub 2014 Jun 25.

33.

Effect of a physical conditioning versus health promotion intervention in dancers: a randomized controlled trial.

Roussel NA, Vissers D, Kuppens K, Fransen E, Truijen S, Nijs J, De Backer W.

Man Ther. 2014 Dec;19(6):562-8. doi: 10.1016/j.math.2014.05.008. Epub 2014 Jun 3.

PMID:
24951437
34.

The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients.

De Backer W, Vos W, Van Holsbeke C, Vinchurkar S, Claes R, Hufkens A, Parizel PM, Bedert L, De Backer J.

Eur Respir J. 2014 Aug;44(2):527-9. doi: 10.1183/09031936.00011714. Epub 2014 May 2. No abstract available.

35.

COPD awareness survey: do Belgian pulmonary physicians comply with the GOLD guidelines 2010?

Decramer M, Brusselle G, Buffels J, Corhay JL, De Backer W, Degryse JM, Janssens W, Marchand E, Van den Brande P, Vincken W, Gayan-Ramirez G, Van Craenendonck V, Vandenberghe H, De Vuyst P; COPD Working Group.

Acta Clin Belg. 2013 Sep-Oct;68(5):325-40.

PMID:
24579239
36.

Usage of inhalation devices in asthma and chronic obstructive pulmonary disease: a Delphi consensus statement.

Ninane V, Brusselle GG, Louis R, Dupont L, Liistro G, De Backer W, Schlesser M, Vincken W.

Expert Opin Drug Deliv. 2014 Mar;11(3):313-23. doi: 10.1517/17425247.2014.872626. Epub 2013 Dec 18.

37.

Functional respiratory imaging as a tool to personalize respiratory treatment in patients with unilateral diaphragmatic paralysis.

Van Holsbeke CS, Leemans G, Vos WG, De Backer JW, Vinchurkar SC, Geldof M, Verdonck PR, Parizel PM, Van Schil PE, De Backer WA.

Respir Care. 2014 Sep;59(9):e127-31. doi: 10.4187/respcare.02756. Epub 2013 Dec 10.

38.

Effect of high-dose N-acetylcysteine on airway geometry, inflammation, and oxidative stress in COPD patients.

De Backer J, Vos W, Van Holsbeke C, Vinchurkar S, Claes R, Parizel PM, De Backer W.

Int J Chron Obstruct Pulmon Dis. 2013;8:569-79. doi: 10.2147/COPD.S49307. Epub 2013 Nov 22.

39.

Objective measurement of the therapeutic effectiveness of continuous positive airway pressure versus oral appliance therapy for the treatment of obstructive sleep apnea.

Vanderveken OM, Braem MJ, Dieltjens M, De Backer WA, Van de Heyning PH.

Am J Respir Crit Care Med. 2013 Nov 1;188(9):1162. doi: 10.1164/rccm.201305-0809LE. No abstract available.

PMID:
24180443
40.

Cardiovascular mechanisms and consequences of obstructive sleep apnoea.

Vrints H, Shivalkar B, Hilde H, Vanderveken OM, Hamans E, Van de Heyning P, De Backer W, Verbraecken J.

Acta Clin Belg. 2013 May-Jun;68(3):169-78. Review.

PMID:
24156215
41.

A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD.

Agustí A, de Teresa L, De Backer W, Zvarich MT, Locantore N, Barnes N, Bourbeau J, Crim C.

Eur Respir J. 2014 Mar;43(3):763-72. doi: 10.1183/09031936.00054213. Epub 2013 Oct 10.

42.

Sleep-disordered breathing and C-reactive protein in obese children and adolescents.

Van Eyck A, Van Hoorenbeeck K, De Winter BY, Ramet J, Van Gaal L, De Backer W, Verhulst SL.

Sleep Breath. 2014 May;18(2):335-40. doi: 10.1007/s11325-013-0890-8. Epub 2013 Sep 3.

PMID:
23999834
43.

Objectively measured vs self-reported compliance during oral appliance therapy for sleep-disordered breathing.

Dieltjens M, Braem MJ, Vroegop AVMT, Wouters K, Verbraecken JA, De Backer WA, Van de Heyning PH, Vanderveken OM.

Chest. 2013 Nov;144(5):1495-1502. doi: 10.1378/chest.13-0613.

PMID:
23928873
44.

Obstructive sleep apnea/hypopnea syndrome.

De Backer W.

Panminerva Med. 2013 Jun;55(2):191-5. Review.

PMID:
23676959
45.

Novel functional imaging of changes in small airways of patients treated with extrafine beclomethasone/formoterol.

Vos W, De Backer J, Poli G, De Volder A, Ghys L, Van Holsbeke C, Vinchurkar S, De Backer L, De Backer W.

Respiration. 2013;86(5):393-401. doi: 10.1159/000347120. Epub 2013 Apr 12.

46.

Change in upper airway geometry between upright and supine position during tidal nasal breathing.

Van Holsbeke CS, Verhulst SL, Vos WG, De Backer JW, Vinchurkar SC, Verdonck PR, van Doorn JW, Nadjmi N, De Backer WA.

J Aerosol Med Pulm Drug Deliv. 2014 Feb;27(1):51-7. doi: 10.1089/jamp.2012.1010. Epub 2013 Mar 19.

PMID:
23509935
47.

Functional respiratory imaging as a tool to assess upper airway patency in children with obstructive sleep apnea.

Van Holsbeke C, Vos W, Van Hoorenbeeck K, Boudewyns A, Salgado R, Verdonck PR, Ramet J, De Backer J, De Backer W, Verhulst SL.

Sleep Med. 2013 May;14(5):433-9. doi: 10.1016/j.sleep.2012.12.005. Epub 2013 Mar 7.

PMID:
23474060
48.

Metabolic disregulation in obese adolescents with sleep-disordered breathing before and after weight loss.

Van Hoorenbeeck K, Franckx H, Debode P, Aerts P, Ramet J, Van Gaal LF, Desager KN, De Backer WA, Verhulst SL.

Obesity (Silver Spring). 2013 Jul;21(7):1446-50. doi: 10.1002/oby.20337. Epub 2013 May 25.

49.

Acute effects of intrapulmonary percussive ventilation in COPD patients assessed by using conventional outcome parameters and a novel computational fluid dynamics technique.

Ides K, Vos W, De Backer L, Vissers D, Claes R, Leemans G, Ongena K, Peters O, De Backer W.

Int J Chron Obstruct Pulmon Dis. 2012;7:667-71. doi: 10.2147/COPD.S29847. Epub 2012 Sep 25.

50.

Particle deposition in airways of chronic respiratory patients exposed to an urban aerosol.

Horemans B, Van Holsbeke C, Vos W, Darchuk L, Novakovic V, Fontan AC, De Backer J, Van Grieken R, De Backer W, De Wael K.

Environ Sci Technol. 2012 Nov 6;46(21):12162-9. doi: 10.1021/es302755s. Epub 2012 Oct 19.

PMID:
23035859

Supplemental Content

Loading ...
Support Center